Merck & Co., Inc. (MRK)
↓ Download CSV- Sector Manufacturing
- Incorporated NJ
- Fiscal year ends Dec 31
In fiscal 2025, Merck & Co., Inc. reported revenue of $65.01B, up 1.3% from the prior year. The company was profitable, with a net margin of 28.1%.
Key ratios (FY2025)
28.1%
Net margin
34.7%
Return on equity
+1.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.01B | $64.17B | $60.12B | $59.28B | $48.70B | $41.52B | $39.12B | $42.29B | $40.12B | $39.81B |
| Cost of Revenue | $16.38B | $15.19B | $16.13B | $17.41B | $13.63B | $13.62B | $12.02B | $13.51B | $12.91B | $14.03B |
| Net Income | $18.25B | $17.12B | $365.00M | $14.52B | $13.05B | $7.07B | $9.84B | $6.22B | $2.39B | $3.92B |
| EPS (Diluted) | $7.28 | $6.74 | $0.14 | $5.71 | $5.14 | $2.78 | $3.81 | $2.32 | $0.87 | $1.41 |
| Total Assets | $136.87B | $117.11B | $106.67B | $109.16B | $105.69B | $91.59B | $84.40B | $82.64B | $87.87B | $95.38B |
| Shareholders' Equity | $52.66B | $46.37B | $37.63B | $46.06B | $38.26B | $25.40B | $26.00B | $26.88B | $34.57B | $40.31B |
| Cash & Equivalents | $14.56B | $13.24B | $6.84B | $12.69B | $8.10B | $8.05B | $9.68B | $7.96B | $6.09B | $6.51B |
| Operating Cash Flow | $16.47B | $21.47B | $13.01B | $19.09B | — | $10.25B | $13.44B | $10.92B | $6.45B | $10.38B |
| Capital Expenditures | $4.11B | $3.37B | $3.86B | $4.39B | $4.45B | — | — | — | — | — |
| Shares Outstanding | 2.51B | 2.54B | 2.55B | 2.54B | 2.54B | 2.54B | 2.58B | 2.68B | 2.75B | 2.79B |
| Dividends Per Share | $3.28 | $3.12 | $2.96 | $2.80 | $2.64 | $2.48 | $2.26 | $1.99 | $1.89 | $1.85 |